Zobrazeno 1 - 10
of 1 140
pro vyhledávání: '"neuromedin u"'
Autor:
Sampson, Catherine M.1 (AUTHOR), Kasper, James M.1 (AUTHOR), Felsing, Daniel E.1 (AUTHOR), Raval, Sweta R.1 (AUTHOR), Ye, Na2 (AUTHOR), Wang, Pingyuan1 (AUTHOR), Patrikeev, Igor3 (AUTHOR), Rytting, Erik4 (AUTHOR), Zhou, Jia1 (AUTHOR), Allen, John A.1 (AUTHOR), Hommel, Jonathan D.1 (AUTHOR) jonathan.hommel@utmb.edu
Publikováno v:
Pharmacology Research & Perspectives. Oct2018, Vol. 6 Issue 5, p1-N.PAG. 11p.
Autor:
Nagai, Hiroaki1 hiroaki.nagai@takeda.com, Kaisho, Tomoko1, Yokoyama, Kotaro1, Asakawa, Tomoko1, Fujita, Hisashi1, Matsumiya, Kouta1, Noguchi, Jiro1, Tsuchimori, Kazue1, Nishizawa, Naoki1, Kanematsu‐Yamaki, Yoko1, Dote, Katsuko1, Inooka, Hiroshi1, Sakamoto, Jun‐ichi1, Ohtaki, Tetsuya1, Asami, Taiji1, Takekawa, Shiro1, Kanematsu-Yamaki, Yoko1 (AUTHOR), Sakamoto, Jun-Ichi1 (AUTHOR)
Publikováno v:
British Journal of Pharmacology. Jan2018, Vol. 175 Issue 2, p359-373. 15p. 2 Color Photographs, 4 Charts, 11 Graphs.
Autor:
Vallöf, Daniel1, Ulenius, Lisa1, Egecioglu, Emil1, Engel, Jörgen A.1, Jerlhag, Elisabet1 Elisabet.Jerlhag@pharm.gu.se, Vallöf, Daniel2 (AUTHOR), Engel, Jörgen A2 (AUTHOR)
Publikováno v:
Addiction Biology. May2017, Vol. 22 Issue 3, p640-651. 12p.
Autor:
Gianfagna, Francesco1,2 francesco.gianfagna@uninsubria.it, Grippi, Claudio1, Ahrens, Wolfgang3,4, Bailey, Mark E. S.5, Börnhorst, Claudia3, De Henauw, Stefan6, Foraita, Ronja3, Koni, Anna C.5, Krogh, Vittorio7, Mårild, Staffan8, Molnár, Dénes9, Moreno, Luis10, Pitsiladis, Yannis11, Russo, Paola12, Siani, Alfonso12, Tornaritis, Michael13, Veidebaum, Toomas14, Iacoviello, Licia1
Publikováno v:
PLoS ONE. 2/24/2017, Vol. 12 Issue 2, p1-13. 13p.
The association of Neuromedin U levels and non-alcoholic fatty liver disease: A comparative analysis
Publikováno v:
Heliyon, Vol 10, Iss 5, Pp e27291- (2024)
This comprehensive study delves into the potential link between Neuromedin U (NmU) serum levels and the development of non-alcoholic fatty liver disease (NAFLD), a condition of increasing global prevalence and significant public health concern. The r
Externí odkaz:
https://doaj.org/article/edf8d3e6fe114f489acaf991dc0d3051
Autor:
Vallöf, Daniel1, Vestlund, Jesper1, Engel, Jörgen A.1, Jerlhag, Elisabet1 Elisabet.Jerlhag@pharm.gu.se
Publikováno v:
PLoS ONE. 5/3/2016, Vol. 11 Issue 5, p1-16. 16p.
Publikováno v:
PLoS ONE. 8/28/2015, Vol. 10 Issue 8, p1-19. 19p.
Autor:
Patrycja Przygodzka, Kamila Soboska, Ewelina Sochacka, Marcin Pacholczyk, Marcin Braun, Hassan Kassassir, Izabela Papiewska-Pająk, Michal Kielbik, Joanna Boncela
Publikováno v:
Cell Communication and Signaling, Vol 20, Iss 1, Pp 1-17 (2022)
Abstract Background Neuromedin U (NMU) was identified as one of the hub genes closely related to colorectal cancer (CRC) progression and was recently shown to be a motility inducer in CRC cells. Its autocrine signalling through specific receptors inc
Externí odkaz:
https://doaj.org/article/af77aad5869f4c03a78c7d79fa083911
Autor:
Luca Botticelli, Emanuela Micioni Di Bonaventura, Fabio Del Bello, Gianfabio Giorgioni, Alessandro Piergentili, Wilma Quaglia, Alessandro Bonifazi, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura
Publikováno v:
Pharmacological Research, Vol 195, Iss , Pp 106875- (2023)
Neuromedin U (NMU) is a bioactive peptide produced in the gut and in the brain, with a role in multiple physiological processes. NMU acts by binding and activating two G protein coupled receptors (GPCR), the NMU receptor 1 (NMU-R1), which is predomin
Externí odkaz:
https://doaj.org/article/a5eef850d2c64716b12e4792c1bcf571
Publikováno v:
Journal of Neuroendocrinology. Dec2013, Vol. 25 Issue 12, p1264-1272. 9p.